Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Decreases Escherichia coli Xuzhou21 - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Characterization and antioxidant activity of nano-formulated berberine and cyperus rotundus extracts with anti-inflammatory effects in mastitis-induced rats. Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 18462 Pub: 2024 Aug 9 Epub: 2024 Aug 9 Authors Hashem AE , Elmasry IH , Lebda MA , El-Karim DRSG , Hagar M , Ebied SKM , Alotaibi BS , Rizk NI , Ghamry HI , Shukry M , Edres HA , Html Article Publication |
| Decreases Escherichia coli Xuzhou21 - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Synthesis of New Derivatives of Berberine Canagliflozin and Study of Their Antibacterial Activity and Mechanism. Molecules (Basel, Switzerland) (Molecules ) Vol: 29 Issue 1 Pages: Pub: 2024 Jan 4 Epub: 2024 Jan 4 Authors Li J , Hou X , Xiao J , Zhu L , Deng Y , Li Z , Zhao Z , Luo Z , Wei H , Html Article Publication |
| Decreases Escherichia coli Xuzhou21 - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Berberine: An inspiring resource for the treatment of colorectal diseases. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 167 Issue Pages: 115571 Pub: 2023 Nov Epub: 2023 Sep 25 Authors Cao F , Xia W , Dai S , Wang C , Shi R , Yang Y , Guo C , Xu XL , Luo J , Publication |
| Decreases Escherichia coli Xuzhou21 - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Assessment of berberine as a multi-target antimicrobial: a multi-omics study for drug discovery and repositioning. Omics : a journal of integrative biology (OMICS ) Vol: 18 Issue 1 Pages: 42-53 Pub: 2014 Jan Epub: 2013 Nov 16 Authors Karaosmanoglu K , Sayar NA , Kurnaz IA , Akbulut BS , Publication |
| Decreases Escherichia coli Xuzhou21 - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Potential antibacterial activity of berberine against multi drug resistant enterovirulent Escherichia coli isolated from yaks (Poephagus grunniens) with haemorrhagic diarrhoea. Asian Pacific journal of tropical medicine (Asian Pac J Trop Med ) Vol: 6 Issue 4 Pages: 315-9 Pub: 2013 Apr 13 Epub: Authors Bandyopadhyay S , Patra PH , Mahanti A , Mondal DK , Dandapat P , Bandyopadhyay S , Samanta I , Lodh C , Bera AK , Bhattacharyya D , Sarkar M , Baruah KK , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
